CMAX - prijevod na Hrvatskom

• cmax
• cmaksimum
• cmaks
• srednje vrijednosti cmax
• cmax-a
• vrijednosti crmaxr

Primjeri korištenja Cmax na Engleski i njihovi prijevodi na Hrvatskom

Administration with a high-fat meal decreased dapagliflozin Cmax by up to 50% and prolonged Tmax by approximately 1 hour, but did not alter AUC as compared with the fasted state.
Primjena lijeka uz punomasan obrok smanjila je vrijednostCmax dapagliflozina do 50% i produljila Tmax za približno 1 sat, ali nije utjecala na AUC u usporedbi s vrijednošću natašte.

After administering a single dose of Vantobra 170 mg to healthy volunteers Cmax of 1.1+ 0.4 µg/ml were reached after a tmax of approximately 4 hours.
Nakon primjene pojedinačne doze lijeka Vantobra 170 mg u zdravih dobrovoljaca, vrijednosti Cmax od 1, 1+ 0, 4 µg/ml dosegnute su u vremenutmax od otprilike četiri sata.

Cmax and AUC were increased following either a high-fat meal(77% and 58%,
Vrijednosti Cmax i AUC povećale su se i nakon obroka s visokim udjelom masti(77% odnosno 58%)

Corresponding steady-state mean Cmax, AUCtau, and Ctrough(mean± SD) were 1.1± 0.40 µg/mL,
Odgovarajuće srednje vrijednosti Cmax, AUCtau i Ctrough(srednje ± SD)

For elvitegravir, Cmax and AUC increased 22% and 36% with a light meal,
Vrijednosti Cmax i AUC za elvitegravir povećale su se 22%,

For elvitegravir, Cmax and AUC increased 22% and 36% with a light meal,
Vrijednosti Cmax i AUC za elvitegravir povećale su se 22%,

For metformin, AUC decreased by 12% and Cmax decreased by 26% compared to fasting conditions.
Za metformin vrijednost AUC se smanjila za 12%, a vrijednost Cmax se smanjila za 26% u usporedbi s uvjetima natašte.

Gender differences in plasma concentrations were observed, Cmax and AUC being approximately 3-and 2-fold higher, respectively, in females compared to males.
Uočene su razlike obzirom na spol u koncentracijama u plazmi, s Cmax i AUC oko 3 odnosno 2 puta višima u žena u usporedbi s muškarcima.

In the presence of digoxin, the Cmax and AUC of ticagrelor and its active metabolite were not affected.
Prisutnost digoksina nije imala učinka na Cmax i AUC tikagrelora i njegovog aktivnog metabolita.

Mean ospemifene Cmax and AUC0-24hr were 785 ng/mL
Srednji Cmax i AUC0-24hr za ospemifen bili su 785 ng/mL odnosno 5448 ng•h/mL,

Mean ruxolitinib Cmax and total exposure(AUC)
Srednji Cmax i ukupna izloženost(AUC) ruksolitinibu razmjerno su

No food effect is expected on Cmax, Tmax and AUC values following CIPII administration.
Ne očekuje se utjecaj hrane na vrijednosti Cmax, Tmax i AUC-a nakon kontinuirane intraperitonejske infuzije inzulina.

The Cmax and AUC following a 2- to 10-minute intravenous infusion of 27 mg/m2 was 4,232 ng/mL
Vrijednosti Cmax odnosno AUC su, nakon2- do 10-minutne intravenske infuzije doze od 27

The mean estimated vorapaxar Cmax and AUC were 35% and 33% higher, respectively, in patients with a body weight of<
Srednja procijenjena vrijednost Cmax i AUC-a vorapaksara bila je 35% odnosno 33% veća u bolesnika tjelesne težine<

The sachet formulation has a slightly higher Cmax than the capsules and thus the formulations are not bioequivalent.
Prašak kao farmaceutski oblik ima nešto višu vrijednost Cmax od kapsula, te stoga ova dva oblika nisu bioekvivalentna.

therefore the peak concentrations Cmax.
stoga vršne koncentracije u plazmi Cmax.

After multipledoses of ticagrelor 90 mg b.i.d. the increase of dabigatran exposure is 1.56-fold and 1.46-fold(+56% and 46%) for Cmax and AUC, respectively.
Nakon višekratnih doza tikagrelora od 90 mg dvaput dnevno izloženost dabigatranu se povećala 1, 56 puta za Cmax i 1, 46 puta za AUC +56% odnosno 46.

As expected, empagliflozin 5 mg administered twice daily compared with 10 mg empagliflozin once daily resulted in lower Cmax and higher trough plasma empagliflozin concentrations Cmin.
Kao što se pretpostavljalo, empagliflozin 5 mg primijenjen dvaput dnevno u usporedbi s empagliflozinom 10 mg primijenjenim jedanput dnevno rezultirao je nižim vrijednostima Cmax i većim najnižim koncentracijama empagliflozina u plazmi Cmin.

At 24 hours, the plasma levels of vardenafil had fallen to approximately 4% of the maximum vardenafil plasma level Cmax.
Nakon 24 sata, razina vardenafila u plazmi snizila se na približno 4% maksimalne razine vardenafila u plazmi Cmax.

Co-administration of a 300 mg tablet with a high fat breakfast reduced maraviroc Cmax and AUC by 33% in healthy volunteers.
Uzimanje tablete od 300 mg istodobno s doručkom s visokim sadržajem masnoća dovodi do smanjenja Cmax i AUC za 33% kod zdravih ispitanika.